Loading your workspace…
All markets
Vaccine for new COVID disease in 2025?
Foretrace AI research
Understand the odds. Examine the reasoning.
Polymarket shows market prices. Foretrace adds AI probability estimates, opposing evidence and a price-dependent outcome or pass decision for each open market.
View a sample AI report No open markets in this event. Closed markets retain historical data.
24h volumeUnavailable
Total volume$10.3K
LiquidityUnavailable
Event end date · UTCDec 31, 2025
Price history
Market probabilityLoading price history…
Polymarket · UTC
Sampled market observations, not AI forecasts. Lines connect available observations. Legend values are current provider quotes; chart points may be older.
Outcomes & resolution rules
1 marketThese are market-implied probabilities, not AI forecasts. A displayed quote may differ from the price available for your order.
ClosedMarket odds0%
Vaccine for new COVID disease in 2025?
Yes0%Polymarket estimate
No100%Polymarket estimate
- Liquidity
- Unavailable
- Deadline · UTC
- Dec 31, 2025
- Yes bid / ask
- 0.2¢ / 1.0¢
- Trading fees
- Not flagged by provider
Closed market · historical data
This market is closed. Its historical data remains available.
How research worksResolution rules
On February 21, a bat coronavirus that has the capacity to spread to humans, known as HKU5-CoV-2, was reportedly discovered (See: https://www.aa.com.tr/en/asia-pacific/china-discovers-new-bat-coronavirus-that-poses-risk-of-animal-to-human-transmission/3489013) This market will resolve to "Yes" if any vaccine intended for humans and inoculating against HKU5-CoV-2 receives full FDA approval between February 20, and December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to "No". The primary resolution source for this market will be information from the FDA, including their official list of approved vaccines (https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states).